首页> 外文期刊>Journal of Clinical Oncology >Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
【24h】

Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

机译:在喉癌治疗中使用喉保存策略:美国临床肿瘤学会临床实践指南更新

获取原文
获取原文并翻译 | 示例
       

摘要

PurposeTo update the guideline recommendations on the use of larynx-preservation strategies in the treatment of laryngeal cancer.MethodsAn Expert Panel updated the systematic review of the literature for the period from January 2005 to May 2017.ResultsThe panel confirmed that the use of a larynx-preservation approach for appropriately selected patients does not compromise survival. No larynx-preservation approach offered a survival advantage compared with total laryngectomy and adjuvant therapy as indicated. Changes were supported for the use of endoscopic surgical resection in patients with limited disease (T1, T2) and for initial total laryngectomy in patients with T4a disease or with severe pretreatment laryngeal dysfunction. New recommendations for positron emission tomography imaging for the evaluation of regional nodes after treatment and best measures for evaluating voice and swallowing function were added.RecommendationsPatients with T1, T2 laryngeal cancer should be treated initially with intent to preserve the larynx by using endoscopic resection or radiation therapy, with either leading to similar outcomes. For patients with locally advanced (T3, T4) disease, organ-preservation surgery, combined chemotherapy and radiation, or radiation alone offer the potential for larynx preservation without compromising overall survival. For selected patients with extensive T3 or large T4a lesions and/or poor pretreatment laryngeal function, better survival rates and quality of life may be achieved with total laryngectomy. Patients with clinically involved regional cervical nodes (N+) who have a complete clinical and radiologic imaging response after chemoradiation do not require elective neck dissection. All patients should undergo a pretreatment baseline assessment of voice and swallowing function and receive counseling with regard to the potential impact of treatment options on voice, swallowing, and quality of life. Additional information is available at www.asco.org/head-neck-cancer-guidelines and www.asco.org/guidelineswiki.
机译:Purposeto更新关于使用喉部癌症的喉部保存策略的指南建议..Thodsan专家小组在2005年1月至2017年5月的时间内更新了对文献的系统审查。议案委员会确认使用喉头preservation approach for appropriately selected patients does not compromise survival.与表明,没有喉保存方法提供生存优势,并如表明的总喉切除术和佐剂治疗。支持有限疾病(T1,T2)患者的内窥镜手术切除和用于T4A疾病患者的初始总喉切除术或严重预处理喉部功能障碍的患者使用内镜手术切除的变化。添加了用于评估治疗后区域节点和评估语音和吞咽功能的最佳措施的正电子发射断层摄影成像的新建议。用T1,T2喉癌应该通过使用内窥镜切除或辐射来保护喉部癌症治疗,均导致类似的结果。对于局部晚期(T3,T4)疾病,器官保存手术,组合化疗和辐射的患者,单独辐射提供喉部保存的可能性而不会损害整体存活。对于具有广泛T3或大T4A病变的选定患者和/或预处理喉函数不佳,可以通过喉切除术来实现更好的存活率和生活质量。临床涉及临床宫颈节点(N +)的患者在化学校长后具有完整的临床和放射学成像反应,不需要选择性颈部解剖。所有患者应经历对语音和吞咽功能的预处理基线评估,并接受关于治疗方案对语音,吞咽和生活质量的潜在影响的咨询。附加信息可在www.asco.org/head-neck-cancer-guidelines和www.asco.org/guidelineswiki获得。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号